Home News Issues My AVMA Jobs Animal Health Public Health @Work Blog Newsletters
Search Tips | Advanced Search     Bookmark and Share
  
Search News
Search within News only.

2011 Convention News
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Search by Headline Listing
JAVMA News Express archive
JAVMA News Photo Galleries

Biosecurity
 
Public Health

AVMA Member area = AVMA/SAVMA  Members Only


Get Adobe reader

Some files on this page require Adobe Reader software. Click on the image above to download it for free from the Adobe site.

 

JAVMA Online News
  Journal of the American Veterinary Medical Association March 15, 2002  

AVMA Journals Home | JAVMA online



TAKE NOTICE
Topical use of nitrofurans banned by FDA

The Food and Drug Administration will soon prohibit all uses of nitrofuran drugs in food-producing animals because they present a public health risk. The ruling is a reaction to evidence that the drugs may induce carcinogenic residues in animal tissues.

Since 1991, nitrofurans have been banned for systemic use in poultry and swine, because the drugs can cause cancer. But topical uses have been allowed, for lack of evidence that this application allows the drugs to reach edible tissues. Now, however, the FDA says it has new evidence that overturns this belief. In a recent study, researchers used carbon-14 radiolabel methods and showed that, in fact, cattle that were treated with ophthalmic preparations had residues of the drugs in their milk and tissues including muscle, kidney, and liver. Because of the risk that these residues could cause cancer, the FDA has decided to tighten regulations and will soon make all uses in food-producing animals illegal. This includes extralabel uses.

Some drug products that will be banned will remain in commercial distribution channels with their old labels that indicate use in food-producing animals. Individuals are reminded, however, that the new rule supersedes these labels and such products cannot be used in food animals.

Nitrofurans, which are effective against a wide range of bacteria, include furazolidone, nitrofurazone, nitrofuratoin, and related compounds.

The rule was published in the Feb. 6, 2002 Federal Register and can be accessed at www.access.gpo.gov/su_docs/fedreg/frcont02.html. Individuals who want to comment on the rule have until April 8, 2002. Unless the FDA modifies the rule or extends the comment period, the rule will go into effect May 7, 2002.

 
Return to top